| Unique ID issued by UMIN | UMIN000059613 |
|---|---|
| Receipt number | R000068106 |
| Scientific Title | A Multi-institutional Prospective Observational Study on Bowel Resection in Patients with Ovarian, Fallopian Tube, or Peritoneal Cancer |
| Date of disclosure of the study information | 2025/11/01 |
| Last modified on | 2025/11/01 08:31:36 |
A study to investigate outcomes in patients with ovarian, fallopian tube, or peritoneal cancer who underwent bowel surgery
Ovarian Cancer Bowel Resection Study
A Multi-institutional Prospective Observational Study on Bowel Resection in Patients with Ovarian, Fallopian Tube, or Peritoneal Cancer
Ovarian Cancer Bowel Resection Study
| Japan |
Stage II-IV ovarian, fallopian tube, or peritoneal cancer
| Gastrointestinal surgery | Obstetrics and Gynecology |
Malignancy
YES
To prospectively investigate the clinical significance of mesenteric lymph node metastasis in patients undergoing rectosigmoid resection for ovarian, fallopian tube, or peritoneal cancer
Others
Clinical significance
1. Rate of rectosigmoid resection
2. Frequency of mesenteric lymph node metastasis in patients who underwent rectosigmoid resection
1. Clinicopathological factors associated with mesenteric lymph node metastasis
2. Progression-free survival (PFS) and overall survival (OS) according to mesenteric lymph node metastasis status
3. Predictive factors for rectosigmoid resection in Stage II-IV ovarian, fallopian tube, or peritoneal cancer
4. Stoma creation and closure rates in rectosigmoid resection
Observational
| 18 | years-old | <= |
| 100 | years-old | >= |
Female
1. Patients who underwent surgery at Niigata University Medical and Dental Hospital or Niigata Cancer Center Hospital
2. Age: 18-100 years
3. Diagnosed with Stage II-IV ovarian, fallopian tube, or peritoneal cancer
4. Including patients who underwent diagnostic laparoscopy only
5. Provided written informed consent
Cases judged inappropriate for study registration by the principal investigator
250
| 1st name | Yoshifumi |
| Middle name | |
| Last name | Shimada |
Niigata University Graduate School of Medical and Dental Sciences
Division of Digestive and General Surgery
951-8510
1-757 Asahimachi-dori, Chuo-ku, Niigata City, Niigata
025-227-2228
shimaday@med.niigata-u.ac.jp
| 1st name | Yoshifumi |
| Middle name | |
| Last name | Shimada |
Niigata University Graduate School of Medical and Dental Sciences
Division of Digestive and General Surgery
951-8510
1-757 Asahimachi-dori, Chuo-ku, Niigata City, Niigata
025-227-2228
shimaday@med.niigata-u.ac.jp
Niigata University
Niigata University
Other
Ethics Committee of Niigata University
1-757 Asahimachi-dori, Chuo-ku, Niigata City, Niigata
025-227-2625
ethics@adm.niigata-u.ac.jp
NO
| 2025 | Year | 11 | Month | 01 | Day |
Unpublished
Open public recruiting
| 2025 | Year | 10 | Month | 30 | Day |
| 2025 | Year | 10 | Month | 29 | Day |
| 2025 | Year | 11 | Month | 01 | Day |
| 2036 | Year | 12 | Month | 31 | Day |
As a non-interventional observational study, follow-up methods are not mandated. However, postoperative follow-up including chest, abdominal, and pelvic CT scans every 3-6 months is recommended. Tumor response evaluation according to the Response Evaluation Criteria in Solid Tumors (RECIST) guidelines version 1.1 (Japanese translation JCOG version 1.0) is recommended. All examinations are performed within standard clinical practice.
| 2025 | Year | 11 | Month | 01 | Day |
| 2025 | Year | 11 | Month | 01 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000068106